#180 Beta-Blockers & REDUCE-AMI Trial: Beyond...

“It didn’t work.” This episode breaks down practical treatment options (dosing options for naltrexone, acamprosate, topiramate, gabapentin) and counseling pearls to help you meet patients where they are and support their recovery. Also discover blind spots in detox and rehab cent ...  Show more

Have you ever lost a patient and found yourself thinking about them long after the shift ended? This episode explores the grief clinicians can carry after a patient dies, including the losses that aren’t always obvious. We also discuss ways to work through that grief, recognize w ...  Show more

Beta-blockers post MI, public perception of statins, trust in the medical profession, BMI, and TAVI are the topics John Mandrola, MD, covers in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript ...

In this episode, Dr Matt and Dr Mike discus drugs that are used to treat cardiovascular diseases.YouTube: https://www.youtube.com/@DrMattDrMike/Email: gubiosciences@gmail.comInstagram: @drmiketodorovicTwitter: @drmiketodorovicTikTok: @dr_mike_todorovicFor the A-Z episodes please ...  Show more

Beta-blockers are commonly used in the management of hypertension as well as rate control for atrial fibrillation. On this episode, I breakdown some of the most common agent and what to look out for. Enjoy the show! All subscribers to the website/podcast will get access to a FREE ...  Show more

AF screening, BNP, a new SGLT2 inhibitor, a sky-is-blue study, and the UK Mini Mitral surgical trial are discussed in this week's podcast

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit: